FDA reportedly intends to authorize Moderna's COVID-19 vaccine on Friday
Another COVID-19 vaccine could be approved in the United States in just a few days.
The U.S. Food and Drug Administration on Tuesday released data confirming that the COVID-19 vaccine developed by Moderna is highly protective after Moderna previously said it has an efficacy rate of 94.1 percent, The New York Times reports. There weren't any serious safety concerns in its clinical trial, the FDA also said.
As a result, the Times reports the FDA "intends to grant emergency authorization for use of the vaccine on Friday," citing sources familiar with the agency's plans. An independent panel is set to meet on Thursday to consider whether to recommend the FDA authorize the vaccine for emergency use.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
In addition to announcing a nearly 95 percent efficacy rate, Moderna also previously said its vaccine is 100 percent effective at preventing severe cases of COVID-19, and the new documents released Tuesday suggested that it can also begin to prevent some asymptomatic infections after the first dose, per CNBC's Meg Tirrell.
Moderna's COVID-19 vaccine would be the second to earn FDA authorization, as last Friday, the FDA approved a coronavirus vaccine developed by Pfizer and BioNTech after an independent panel recommended it do so. By Monday, the first American health care workers began to receive it.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Brendan worked as a culture writer at The Week from 2018 to 2023, covering the entertainment industry, including film reviews, television recaps, awards season, the box office, major movie franchises and Hollywood gossip. He has written about film and television for outlets including Bloody Disgusting, Showbiz Cheat Sheet, Heavy and The Celebrity Cafe.
-
Today's political cartoons - November 12, 2024
Cartoons Tuesday's cartoons - judgemental looks, Europe's bumpy ride, and more
By The Week US Published
-
Will Gary Lineker's departure be an own goal for the BBC?
Today's Big Question Former star striker turned highest-paid presenter will leave Match of the Day after 25 years, with BBC head of sport reportedly declining to offer him a contract
By Harriet Marsden, The Week UK Published
-
The potential impact of Trump tariffs for the UK
The Explainer UK goods exports to the US could be hit with tariffs of up to 20% seriously affecting the British economy
By Sorcha Bradley, The Week UK Published
-
ACA opens 2025 enrollment, enters 2024 race
Speed Read Mike Johnson promises big changes to the Affordable Care Act if Trump wins the election
By Peter Weber, The Week US Published
-
McDonald's sued over E. coli linked to burger
Speed Read The outbreak has sickened at least 49 people in 10 states and left one dead
By Rafi Schwartz, The Week US Published
-
Texas dairy worker gets bird flu from infected cow
Speed Read The virus has been spreading among cattle in Texas, Kansas, Michigan and New Mexico
By Peter Weber, The Week US Published
-
Dengue hits the Americas hard and early
Speed Read Puerto Rico has declared an epidemic as dengue cases surge
By Peter Weber, The Week US Published
-
US bans final type of asbestos
Speed Read Exposure to asbestos causes about 40,000 deaths in the U.S. each year
By Peter Weber, The Week US Published
-
Seattle Children's Hospital sues Texas over 'sham' demand for transgender medical records
Speed Read Texas Attorney General Ken Paxton subpoenaed records of any Texan who received gender-affirming care at the Washington hospital
By Peter Weber, The Week US Published
-
Afghanistan has a growing female suicide problem
Speed Read The Taliban has steadily whittled away women's and girls' rights in Afghanistan over the past 2 years, prompting a surge in depression and suicide
By Peter Weber, The Week US Published
-
US life expectancy rose in 2022 but not to pre-pandemic levels
Speed Read Life expectancy is slowly crawling back up
By Devika Rao, The Week US Published